A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant.
about
Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.Cellular environment-responsive nanomaterials for use in gene and siRNA delivery: molecular design for biomembrane destabilization and intracellular collapse.Tumour acidosis: from the passenger to the driver's seat.The Circular RNA Interacts with STAT3, Increasing Its Nuclear Translocation and Wound Repair by Modulating Dnmt3a and miR-17 Function.Engineering nanoparticles to overcome barriers to immunotherapy.
P2860
A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A KALA-modified lipid nanopart ...... n immune-stimulative adjuvant.
@ast
A KALA-modified lipid nanopart ...... n immune-stimulative adjuvant.
@en
type
label
A KALA-modified lipid nanopart ...... n immune-stimulative adjuvant.
@ast
A KALA-modified lipid nanopart ...... n immune-stimulative adjuvant.
@en
prefLabel
A KALA-modified lipid nanopart ...... n immune-stimulative adjuvant.
@ast
A KALA-modified lipid nanopart ...... n immune-stimulative adjuvant.
@en
P2093
P2860
P356
P1476
A KALA-modified lipid nanopart ...... n immune-stimulative adjuvant.
@en
P2093
Hidetaka Akita
Hideyoshi Harashima
Naoya Miura
Sharif M Shaheen
Takashi Nakamura
P2860
P304
P356
10.1093/NAR/GKV008
P407
P577
2015-01-20T00:00:00Z